Stay updated with breaking news from Prosense System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAESAREA, Israel - IceCure Medical Ltd. , developer of the ProSense System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal,...
IceCure Medical Ltd. has announced that the Food and Drug Administration (FDA) has granted its appeal and reopened its De Novo Classification Request for Marketing Authorization of its ProSense cryoablation technology for early-stage breast cancer.
By Chris Wack IceCure Medical shares shot up 61% to $1.19 after the company said it saw positive results in a trial for its ProSense System, a...
IceCure Medical Ltd (NASDAQ: ICCM) shares skyrocketed 105.35% in the pre-market session trading on promising research results.
By Colin Kellaher IceCure Medical shares rallied Monday after the medical-device company said an independent study concluded that cryoablation could be an...